Evidence map›Paper›PMID 31258967›Full record

ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2019

Genetically-guided algorithm development and sample size optimization for age-related macular degeneration cases and controls in electronic health records from the VA Million Veteran Program.

Christopher W Halladay, Tamer Hadi, Matthew D Anger, Paul B Greenberg, Jack M Sullivan, P Eric Konicki, Neal S Peachey, Robert P Igo, Sudha K Iyengar, Wen-Chih Wu and 2 more

Abstract read
In one paragraph

Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christopher W HalladayCenter for Innovation in Long Term Services and Supports, Providence VA Medical Center, Providence, RI.
Tamer HadiDepartment of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Cleveland, OH.
Matthew D AngerResearch Service, VA Western NY Healthcare System, Buffalo, NY.
Paul B GreenbergSection of Ophthalmology, Providence VA Medical Center, Providence, RI.
Jack M SullivanResearch Service, VA Western NY Healthcare System, Buffalo, NY.
P Eric KonickiLouis Stokes Cleveland VA Medical Center, Cleveland, OH.
Neal S PeacheyLouis Stokes Cleveland VA Medical Center, Cleveland, OH.
Robert P IgoLouis Stokes Cleveland VA Medical Center, Cleveland, OH.
Sudha K IyengarDepartment of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Cleveland, OH.
Wen-Chih WuSection of Cardiology, Medical Service, Providence VA Medical Center, Providence, RI.
Dana C CrawfordLouis Stokes Cleveland VA Medical Center, Cleveland, OH.
VA Million Veteran Program

Funding

Genetic Risk for AMD in Diverse Veteran PopulationsI01BX003364 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI KONICKI, P. ERIC, PEACHEY, NEAL S. · 2016 to 2016
–
Deciphering Genetic and Environmental Influences on Visual Disorders in the Million Veteran ProgramI01BX004557 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI PEACHEY, NEAL S. · 2019 to 2025
–
BLRD VA I01 BX003364BLRD VA I01 BX004557BLRD VA IK6 BX005233
6 · The paper itself

Abstract

Electronic health records (EHRs) linked to extensive biorepositories and supplemented with lifestyle, behavioral, and environmental exposure data, have enormous potential to contribute to genomic discovery, a necessary step in the pathway towards translational or precision medicine. A major bottleneck in incorporating EHRs into genomic studies is the extraction of research-grade variables for analysis, particularly when gold-standard measurements are not available or accessible. Here we develop algorithms for age-related macular degeneration (AMD), a common cause of blindness among the elderly, and controls free of AMD. These computable phenotypes were developed using billing codes (ICD-9-CM and ICD-10-CM) and Current Procedural Terminology (CPT) codes and evaluated in two study sites of the Veterans Affairs Million Veteran Program: Louis Stokes Cleveland VA Medical Center and the Providence VA Medical Center. After establishing a high overall positive and negative predictive values (93% and 95%, respectively) through manual chart review, the candidate algorithm was deployed in the full VA MVP dataset of >500,000 participants. The algorithm was then optimized in a data cube using a variety of approaches including adjusting inclusion age thresholds by examining previously-reported genetic associations for

Indexed as

age-related macular degenerationelectronic health recordsgenetic association studyMillion Veteran Program

Identifiers

PMID31258967
PMCPMC6568141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.